Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
1,993 recalls · newest first
Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit
Superpotent; sodium benzoate preservative
Presence of Foreign Tablets/Capsules
CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.
CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.
CGMP Deviations; product intended for quarantine was inadvertently distributed
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)
Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term…
Failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.
CGMP Deviations